{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:28:35Z","timestamp":1789766915362,"version":"4.0.1"},"reference-count":34,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T00:00:00Z","timestamp":1487289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KFO 106"],"award-info":[{"award-number":["KFO 106"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TP5"],"award-info":[{"award-number":["TP5"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vascular damage is aggravated in animal models of hypertension with mineralocorticoid (<jats:styled-content style=\"fixed-case\">MR<\/jats:styled-content>) excess and in hypertensive patients with primary hyperaldosteronism. <jats:styled-content style=\"fixed-case\">MR<\/jats:styled-content> antagonism has shown to provide effective blood pressure (<jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content>)\u2010control in patients with treatment resistant hypertension (<jats:styled-content style=\"fixed-case\">TRH<\/jats:styled-content>), but the concurrent effects on the vasculature have not been examined. In a randomized, double\u2010blinded, placebo\u2010controlled parallel\u2010group study, 51 patients with <jats:styled-content style=\"fixed-case\">TRH<\/jats:styled-content> received either eplerenone 50 mg or placebo for 6\u00a0months together with additional antihypertensives titrated to achieve a <jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content> target of &lt;140\/90\u00a0mm\u00a0Hg. Pulse wave velocity (<jats:styled-content style=\"fixed-case\">PWV<\/jats:styled-content>), augmentation index (<jats:styled-content style=\"fixed-case\">AI<\/jats:styled-content>x), augmentation pressure (<jats:styled-content style=\"fixed-case\">AP<\/jats:styled-content>), <jats:styled-content style=\"fixed-case\">AP<\/jats:styled-content> normalized to a heart rate of 75\/min (<jats:styled-content style=\"fixed-case\">AP<\/jats:styled-content>@<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>75), renal resistive index (<jats:styled-content style=\"fixed-case\">RRI<\/jats:styled-content>), intima\u2010media thickness (<jats:styled-content style=\"fixed-case\">IMT<\/jats:styled-content>) and urinary albumin excretion rate (<jats:styled-content style=\"fixed-case\">UAER<\/jats:styled-content>) were assessed before and after treatment. <jats:styled-content style=\"fixed-case\">PWV<\/jats:styled-content> was reduced only with eplerenone (from 11.3\u00b13.6 to 9.8\u00b12.6\u00a0m\/s, <jats:italic>P<\/jats:italic>\u02c2.001), but not with placebo (10.3\u00b12.0 to 10.1\u00b11.8\u00a0m\/s, <jats:italic>P<\/jats:italic>=.60), despite similar reductions in <jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content> (\u221235\u00b120\/\u221215\u00b111\u00a0mm\u00a0Hg vs \u221230\u00b119\/\u221213\u00b17\u00a0mm\u00a0Hg, n.s.). Further, reductions in <jats:styled-content style=\"fixed-case\">AP<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">AP<\/jats:styled-content>@<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>75 were greater with eplerenone, while changes in <jats:styled-content style=\"fixed-case\">AI<\/jats:styled-content>x, <jats:styled-content style=\"fixed-case\">RRI<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> IMT<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">UAER<\/jats:styled-content> were similar. Our data show that eplerenone beneficially affects markers of arterial stiffness and wave reflection in patients with <jats:styled-content style=\"fixed-case\">TRH<\/jats:styled-content>, independently of <jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content> lowering. These data add to the evidence that <jats:styled-content style=\"fixed-case\">MR<\/jats:styled-content> antagonism should be the preferred treatment option in <jats:styled-content style=\"fixed-case\">TRH<\/jats:styled-content>.<\/jats:p>","DOI":"10.1111\/jch.12986","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T05:22:44Z","timestamp":1487308964000},"page":"669-676","source":"Crossref","is-referenced-by-count":32,"title":["Low dose\u2010eplerenone treatment decreases aortic stiffness in patients with resistant hypertension"],"prefix":"10.1111","volume":"19","author":[{"given":"Tatjana","family":"Kalizki","sequence":"first","affiliation":[{"name":"Department of Nephrology and Hypertension University Hospital of the Friedrich\u2010Alexander\u2010University Erlangen\u2010N\u00fcrnberg  Erlangen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard M.W.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension Hannover Medical School  Hannover Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Raff","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension University Hospital of the Friedrich\u2010Alexander\u2010University Erlangen\u2010N\u00fcrnberg  Erlangen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Reinold","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension University Hospital of the Friedrich\u2010Alexander\u2010University Erlangen\u2010N\u00fcrnberg  Erlangen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension University Hospital of the Friedrich\u2010Alexander\u2010University Erlangen\u2010N\u00fcrnberg  Erlangen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus P.","family":"Schneider","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension University Hospital of the Friedrich\u2010Alexander\u2010University Erlangen\u2010N\u00fcrnberg  Erlangen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2356-5883","authenticated-orcid":false,"given":"Roland E.","family":"Schmieder","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension University Hospital of the Friedrich\u2010Alexander\u2010University Erlangen\u2010N\u00fcrnberg  Erlangen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schneider","sequence":"additional","affiliation":[{"name":"Divisions of Nephrology and Intensive Care Medicine Department of Internal Medicine University Hospital W\u00fcrzburg and Comprehensive Heart Failure Center W\u00fcrzburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.5.1432"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.arrt.2004.02.008"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/2012.jama.10503"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.33.5.1111"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.37.5.1236"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01096.2001"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.31.1.451"},{"key":"e_1_2_8_9_1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/cs1030425","article-title":"Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone\u2010induced vasculopathy","volume":"103","author":"Farquharson CA","year":"2002","journal-title":"Clin Sci"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000083298.23119.16"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32831286fd"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(97)00301-4"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000259805.18468.8c"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.169961"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00257-3"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283599b6a"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816121-00033"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs0950669"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1159\/000097034"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcu.20906"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V12122759"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2005.02363.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.83.6.1849"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.03.066"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000128420.01881.aa"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12860"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.103267"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000067463.13172.EA"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2013.05.058"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1042\/CS20130200"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064549"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283622e58"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12433"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32833487b8"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.10.061"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjch.12986","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jch.12986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T10:36:22Z","timestamp":1693996582000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jch.12986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1111\/jch.12986"],"URL":"https:\/\/doi.org\/10.1111\/jch.12986","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,17]]}}}